DXCM vs ECPG · P/E 63, rev $4.03B vs P/E 6.3, rev $1.32B
DexCom Inc (DXCM) versus Encore Capital Group Inc (ECPG) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Encore Capital Group Inc (ECPG) is a credit services company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported ECPG revenue for 2024-12-31 was $1.32B. Net income was -$139.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
Not investment advice. Open the DXCM and ECPG stock pages for the full models.
Not investment advice.